Shigella antimicrobial drug resistance mechanisms, 2004–2014

Emerging Infectious Diseases

Volumn 22, Issue 6, 2016, Pages 1083-1085

  Nüesch Inderbinen, Magdalena ^a   Heini, Nicole ^a   Zurfluh, Katrin ^a   Althaus, Denise ^a   Hächler, Herbert ^a   Stephan, Roger ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFALOTIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; KANAMYCIN; MACROLIDE; NALIDIXIC ACID; QUINOLONE; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTERIACEAE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; NONHUMAN; POLYMERASE CHAIN REACTION; SCEDOSPORIUM BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; WORLD HEALTH ORGANIZATION; BACTERIAL GENE; DRUG EFFECTS; GENETICS; HISTORY; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; SHIGELLA; SWITZERLAND;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; GENES, BACTERIAL; HISTORY, 21ST CENTURY; HUMANS; MICROBIAL SENSITIVITY TESTS; SHIGELLA; SWITZERLAND;

EID: 84969144808     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2206.152088     Document Type: Article

References (14)

1. World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. Geneva: WHO Document Production Services; 2005. p. 1–14.
2. Holt KE, Baker S, Weill FX, Holmes EC, Kitchen A, Yu J, et al. Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nat Genet. 2012;44:1056–9. http://dx.doi.org/10.1038/ng.2369
3. Connor TR, Barker CR, Baker KS, Weill F-X, Talukder KA, Smith AM, et al. Species-wide whole genome sequencing reveals historical global spread and recent local persistence in Shigella flexneri. Elife. 2015;4:e07335. http://dx.doi.org/10.7554/eLife.07335
4. Livio S, Strockbine NA, Panchalingam S, Tennant SM, Barry EM, Marohn ME, et al. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin Infect Dis. 2014;59:933–41. http://dx.doi.org/10.1093/cid/ciu468
5. Gu B, Cao Y, Pan S, Zhuang L, Yu R, Peng Z, et al. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. Int J Antimicrob Agents. 2012;40:9–17. http://dx.doi.org/10.1016/j.ijantimicag.2012.02.005
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 21st informational supplement. Wayne (PA): The Institute; 2011.
7. Karczmarczyk M, Martins M, McCusker M, Mattar S, Amaral L, Leonard N, et al. Characterization of antimicrobial resistance in Salmonella enterica food and animal isolates from Colombia: identification of a qnrB19-mediated quinolone resistance marker in two novel serovars. FEMS Microbiol Lett. 2010;313:10–9. http://dx.doi.org/10.1111/j.1574-6968.2010.02119.x
8. Geser N, Stephan R, Hächler H. Occurrence and characteristics of extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae in food producing animals, minced meat and raw milk. BMC Vet Res. 2012;8:21. http://dx.doi.org/10.1186/1746-6148-8-21
9. Ojo KK, Ulep C, Van Kirk N, Luis H, Bernardo M, Leitao J, et al. The mef(A) gene predominates among seven macrolide resistance genes identified in gram-negative strains representing 13 genera, isolated from healthy Portuguese children. Antimicrob Agents Chemother. 2004;48:3451–6. http://dx.doi.org/10.1128/AAC.48.9.3451-3456.2004
10. Thompson CN, Duy PT, Baker S. The rising dominance of Shigella sonnei: an intercontinental shift in the etiology of bacillary dysentery. PLoS Negl Trop Dis. 2015;9:e0003708. http://dx.doi.org/10.1371/journal.pntd.0003708
11. Folster JP, Pecic G, Bowen A, Rickert R, Carattoli A, Whichard JM. Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009. Antimicrob Agents Chemother. 2011;55:1758–60. http://dx.doi.org/10.1128/AAC.01463-10
12. De Lappe N, O’Connor J, Garvey P, McKeown P, Cormican M. Ciprofloxacin-resistant Shigella sonnei associated with travel to India. Emerg Infect Dis. 2015;21:894–6. http://dx.doi.org/10.3201/eid2105.141184
13. Rossolini GM, Dandrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect. 2008; 14:33–41. http://dx.doi.org/10.1111/j.1469-0691.2007.01867.x
14. Lin L, Nonejuie P, Munguia J, Hollands A, Olson J, Dam Q, et al. Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens. EBioMedicine. 2015;2:690–8. http://dx.doi.org/10.1016/j.ebiom.2015.05.021